Manus Aktteva
We are only a phone call away, Call us on: +91 79 65123395
+91 79 26463395
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Manus Aktteva offers Fondaparinux Sodium's n-3 Intermediate, having cas no 114903-05-8, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates
Products A to Z
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  Molecular Formula
Quick Help
Tel1: +91 79 65123395
Tel2: +91 79 26463395
Email: click here
Twitter  Facebook
N-3 Intermediate of Fondaparinux Sodium
N-3 Intermediate of Fondaparinux Sodium
Manus Aktteva Biopharma LLP offers Fondaparinux Sodium's n-3 Intermediate, MethylO-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-Obenzyl-ß-D-glucopyranosyluronicacid)-(1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl-2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside, having cas no 114903-05-8, for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
Product Reference ID: MA-ZO-1023-O
114903-05-8, N-3,Intermediate,Fondaparinux Sodium
Chemical Name: Fondaparinux Sodium N-3 Intermediate
CAS number 114903-05-8
Synonym MethylO-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-Obenzyl-ß-D-glucopyranosyluronicacid)-(1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl-2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside,N-3 Intermediate, Fondaparinux
Molecular Formula C81H91N7O27
Molecular Weight 1593.60
Specifications Detailed Certificate Of Analysis available on request
Packing Export worthy packing
Application Fondaparinux Sodium
Material Safety Data Sheet
Available on request
Availability For your requirements of evaluation, Pilots and Commercial procurement
Comments NMR, HNMR, HPLC, Method Of Analysis, Impurities in most cases available with shipment.
Back to Previous Page Click here to Inquire
Are you looking for Fondaparinux Sodium ? Please click here to browse through the Fondaparinux Sodium page.
Are you looking for Fondaparinux Sodium Intermediates ? Please click here to browse through the list of Fondaparinux Sodium Intermediates available with us.
MethylO-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-Obenzyl-ß-D-glucopyranosyluronicacid)-(1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl-2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside, 114903-05-8, N-3 Intermediate of Fondaparinux Sodium, India, China, Manufacturers, Suppliers, Manufacturer, supplier, N-3 Intermediate, Fondaparinux
  • Manus Aktteva Biopharma LLP, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2019 MANUS AKTTEVA  All rights reserved..
Payment Procedure